Evonik Rexim (Nanning) Pharm. Co. v. United States
Opinion
Plaintiffs Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. and Evonik Corporation (collectively, "Evonik") challenge the final decision issued by the U.S. Department of Commerce ("Commerce" or
*1414
"Department") in the administrative review of the antidumping duty order of glycine from the People's Republic of China for the 2013-2014 period of review.
SeeGlycine From the People's Republic of China
,
Evonik challenged (1) Commerce's determination that its sales were not
bona fide
and (2) the application of the 453.79 percent China-wide entity rate during the 2013-2014 administrative review.
Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. v. United States
, 41 CIT ----, ----,
Before the court are Commerce's final results of redetermination submitted following the court's grant of a voluntary remand issued on March 23, 2018. See Final Results of Redetermination Pursuant to Court Remand, June 5, 2018, ECF No. 9 (" Remand Redetermination "). For the following reasons, the court sustains the Remand Redetermination.
BACKGROUND
Commerce found in the underlying administrative review that Evonik's sales of subject merchandise were not bona fide . See Final IDM at 24. Commerce assigned Evonik the China-wide entity rate of 453.79 percent, which was based on the rate assigned to Baoding Mantong Fine Chemistry Co., Ltd. ("Baoding") in the final results of the antidumping administrative review on glycine from China for 2010-2011. Remand Redetermination at 1-2.
In a proceeding separate from this litigation, Baoding challenged the 453.79 percent rate and the court issued a remand for Commerce to reconsider the rate and underlying analysis.
Baoding Mantong Fine Chemistry Co., Ltd. v. United States
, 41 CIT ----, ----,
After the Baoding Mantong court sustained Commerce's Second Remand Redetermination reducing Baoding's weighted-average dumping margin to 0.00 percent, this court granted Defendant's Consent Motion for Voluntary Remand. Order, Mar. 23, 2018, ECF No. 6. In its Remand Redetermination, Commerce vacated the China-wide entity rate of 453.79 percent and assigned an adjusted rate of 155.89 percent, which Commerce explained was the previous China-wide entity rate established in the underlying less-than-fair-value investigation. Remand Redetermination at 2, 4. Evonik did not challenge Commerce's proposed adjusted China-wide entity rate of 155.89 percent. Id. at 3. Evonik did not provide comments regarding the Remand Redetermination to the court.
JURISDICTION AND STANDARD OF REVIEW
The court has jurisdiction over Commerce's final determination in an administrative review of an antidumping duty order.
See
ANALYSIS
The Baoding Mantong court sustained Commerce's vacating of the previous China-wide entity rate of 453.79 percent based on substantial evidence considered in the Second Remand Redetermination. After the Baoding Mantong case invalidated the rate of 453.79 percent, Commerce reconsidered the appropriate rate to apply in the instant case. Commerce decided to apply the China-wide entity rate of 155.89 percent that had been established in the underlying less-than-fair-value investigation prior to the selection of the rate of 453.79 percent. The court concludes that Commerce's selection of the China-wide entity rate of 155.89 percent is reasonable. Plaintiffs Evonik do not challenge the rate of 155.89 percent and have waived any objections by declining to submit comments on the Remand Redetermination to the court. The court sustains Commerce's Remand Redetermination.
Judgment will be issued accordingly.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.